logo
Dev IT shares jump 7% after order win from NICSI; check details here

Dev IT shares jump 7% after order win from NICSI; check details here

Shares of Dev Information Technology rose nearly 7 per cent on Tuesday after the company received a ₹1.29 crore order from NICSI for Integrated Financial Management System.
The IT-enabled services firm's stock rose as much as 6.6 per cent during the day to ₹120.8 per share. The stock pared gains to trade 4.9 per cent higher at ₹118.9 apiece, compared to a 0.06 per cent decline in BSE Sensex as of 12:15 PM.
Shares of the company have risen for the second straight session, but are a long way off from their all-time high level of ₹191 per share. The counter has risen nearly 29 per cent so far this year, compared to a 5.3 per cent gain in the benchmark Sensex index. Dev IT has a total market capitalisation of ₹268.04 crore.
Dev IT bags ₹1.29 crore order
The company landed a key order from the National Informatics Centre Services Incorporated (NICSI) to develop an Integrated Financial Management System (IFMS), according to an exchange filing. The project, valued at approximately ₹1.29 crore, aims to streamline and digitise the state's financial management operations, it said.
The IFMS will be a comprehensive digital platform encompassing various core financial functions, including pension and employee management, works accounts, bank disbursement engine, core treasury operations, online bill payments, and budget and expenditure management. The project also includes mobile application development and other key components of IFMS.
The project is expected to be executed within a period of two to three months, according to the statement.
"Securing this project highlights DEVIT's proven capabilities in delivering complex, large-scale government technology solutions," the company said in the filing. "Our success is rooted in a deep understanding of the client's operational needs, a customised and innovative approach to solution design, and a strong, collaborative delivery model."
About Dev IT
Founded in 1997 and listed on both NSE and BSE, Dev IT has grown from a small business automation software provider into a global IT services company.
Headquartered in Ahmedabad with offices across India and in Canada, the company focuses on delivering digital transformation through continuous innovation, technological expertise, and a client-centric approach.
Dev IT collaborates closely with clients to understand their goals and deliver tailored IT solutions that drive business success.
The company offers a wide range of services, including Cloud Services, Digital Transformation, Enterprise Applications, Managed IT Services, and Application Development.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hexaware Appoints Shantanu Baruah to Lead Healthcare, Life Sciences, and Insurance Globally
Hexaware Appoints Shantanu Baruah to Lead Healthcare, Life Sciences, and Insurance Globally

Business Standard

time2 hours ago

  • Business Standard

Hexaware Appoints Shantanu Baruah to Lead Healthcare, Life Sciences, and Insurance Globally

PRNewswire Iselin (New Jersey) [US], August 1: Hexaware Technologies (NSE: HEXT), a global IT solutions company, today announced the appointment of Shantanu Baruah as President & Global Head - Healthcare, Life Sciences & Insurance (H & I). He will be based out of the company's New Jersey office and will lead Hexaware's global strategy, growth, and client success initiatives across the vertical. With over 25 years of experience in the healthcare and life sciences industry, Shantanu brings deep domain expertise and a proven track record of building high-performing teams, driving strategic growth, and leading complex client transformations. Prior to joining Hexaware, he served as Executive Vice President at HCLTech, where he led the Healthcare vertical during one of the industry's most disruptive periods and played a pivotal role in expanding business in the Americas. At a time when AI is reshaping everything from drug discovery to diagnostics and preventive care, Shantanu's appointment underscores Hexaware's commitment to delivering real-world impact. With AI and data at the core, Hexaware is focused on helping clients enhance patient outcomes, accelerate innovation, and drive operational efficiencies -- critical pillars shaping the future of healthcare. R Srikrishna, CEO of Hexaware, said, "We're excited to have Shantanu join Hexaware at a time of exciting momentum in our Healthcare, Life Sciences, and Insurance business. His leadership and deep market knowledge will be instrumental in helping our clients navigate the next era of digital health, patient-centric care, and AI-powered innovation." Commenting on his appointment, Shantanu Baruah said, "I'm delighted to join Hexaware and lead the next phase of growth in the H & I vertical. The industry is at an inflection point, and Hexaware's agile culture, customer-first mindset, and AI-led and human intelligence perfected approach make it ideally positioned to partner with clients in delivering better outcomes." Shantanu holds a master's degree in computer applications and a bachelor's degree in zoology, a combination that brings both technical and scientific perspectives to his leadership. This appointment reflects Hexaware's continued focus on strengthening domain leadership and scaling vertical-centric growth to address the evolving needs of global clients. About Hexaware Hexaware is a global technology and business process services company. Every day, Hexawarians wake up with a singular purpose: to create smiles through great people and technology. With offices across the world, we empower enterprises worldwide to realize digital transformation at scale and speed by partnering with them to build, transform, run, and optimize their technology and business processes. Learn more about Hexaware at Photo: Logo:

Markets extend losses on global sell-off amid US tariff concerns; Sensex tanks 586 points
Markets extend losses on global sell-off amid US tariff concerns; Sensex tanks 586 points

The Print

time2 hours ago

  • The Print

Markets extend losses on global sell-off amid US tariff concerns; Sensex tanks 586 points

As many as 2,712 stocks declined while 1,306 advanced and 151 remained unchanged on the BSE. Besides, persistent selling by foreign investors added to the gloom, according to experts. In a volatile trade, the 30-share BSE Sensex tumbled 585.67 points or 0.72 per cent to settle at 80,599.91. During the day, it dropped 690.01 points or 0.84 per cent to 80,495.57. Mumbai, Aug 1 (PTI) Equity benchmark indices Sensex and Nifty declined sharply for the second straight session on Friday, tracking deep losses in pharma, metal, and IT stocks amid trade-related concerns and widespread selling pressure in global markets. The 50-share NSE Nifty declined 203 points or 0.82 per cent to 24,565.35. 'The benchmark index Nifty wrapped up its fifth consecutive week in the red — its longest losing streak since August 2023, raising eyebrows across the street…Despite making multiple attempts to scale up, the index has struggled to hold ground, only to be met with selling pressure each time. The long upper wicks are a telling story — bulls tried, but bears had the final say,' Sudeep Shah, Head – Technical Research and Derivatives at SBI Securities, said. On the weekly front, the BSE benchmark tanked 863.18 points or 1.05 per cent, and the Nifty dropped 271.65 points or 1.09 per cent. 'The Indian equity market extended its decline for a second day, pressured by renewed tariff threats and punitive duties that could undermine India's global trade competitiveness. Investor sentiment weakened further as FIIs now hold the second-highest net short position in derivatives, reflecting elevated caution. 'Globally, markets turned negative amid rising US inflation and trade tensions. While the sell-off was broad-based, FMCG stocks emerged as a defensive play, supported by attractive valuations, resilient demand, and relative immunity to external trade disruptions,' Vinod Nair, Head of Research, Geojit Investments Limited, said. US President Donald Trump unveiled sweeping new tariffs on dozens of countries, including 25 per cent duties for goods from India, marking a new era of American protectionism that triggered fresh tensions and concerns over a much wider disruption in the global trade landscape. From the Sensex firms, Sun Pharma tumbled 4.43 per cent after the company reported a 20 per cent year-on-year decline in consolidated net profit to Rs 2,279 crore for the first quarter ended June 30, 2025. Tata Steel, Maruti, Tata Motors, Infosys, Bharti Airtel and Tech Mahindra were also among the laggards. However, Trent, Asian Paints, Hindustan Unilever, ITC, Kotak Mahindra Bank, and Reliance Industries were the gainers. The BSE smallcap gauge dropped 1.59 per cent, and the midcap index declined by 1.37 per cent. Healthcare tanked 2.44 per cent, telecommunication (2.41 per cent), metal (1.94 per cent), oil & gas (1.91 per cent), teck (1.83 per cent), IT (1.81 per cent), and realty (1.78 per cent). BSE FMCG index emerged as the only gainer. 'Markets began the August series on a negative note, extending the prevailing corrective trend, and ended lower by over half a per cent. Markets continue to grapple with a mixed earnings season, while the recent tariff announcement and persistent foreign fund outflows are further weighing on sentiment,' Ajit Mishra – SVP, Research, Religare Broking Ltd, said. The US president signed an executive order on Thursday that raised tariffs for over five dozen countries, with Washington's negotiations for trade deals going down to the wire ahead of the August 1 deadline. In the Executive Order titled 'Further Modifying The Reciprocal Tariff Rates', Trump announced tariff rates for nearly 70 nations. A 25 per cent 'Reciprocal Tariff, Adjusted' has been imposed on India, according to the list released. The order, however, does not mention the 'penalty' that Trump had said India would have to pay because it purchases Russian military equipment and energy. While August 1 was the tariff deadline, the new levies will come into effect from August 7. Foreign Institutional Investors (FIIs) offloaded equities worth Rs 5,588.91 crore on Thursday, according to exchange data. 'Global equity markets were mostly weak over the past week, as the US tariff saga continued. The Indian equity market continued to underperform global equity markets in the past week and was down 0.8 per cent over this period,' Shrikant Chouhan, Head – Equity Research, said. In Asian markets, South Korea's Kospi, Japan's Nikkei 225 index, Shanghai's SSE Composite index and Hong Kong's Hang Seng settled lower. Equity markets in Europe were trading in the red. The US markets ended in negative territory on Thursday. Global oil benchmark Brent crude declined 0.39 per cent to USD 71.42 a barrel. On Thursday, the Sensex declined 296.28 points or 0.36 per cent to settle at 81,185.58. The Nifty dropped 86.70 points or 0.35 per cent to 24,768.35. PTI SUM SUM BAL BAL This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.

Sebi proposes tighter norms for green bond third-party reviewers
Sebi proposes tighter norms for green bond third-party reviewers

Economic Times

time2 hours ago

  • Economic Times

Sebi proposes tighter norms for green bond third-party reviewers

(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .) Subscribe to ET Prime and read the Economic Times ePaper Sensex Today. Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store